{
    "url_original": "https://www.wsj.com/articles/endo-begins-debt-restructuring-talks-with-creditors-11652889472?mod=markets_major_pos15",
    "url": "endo-begins-debt-restructuring-talks-with-creditors-11652889472",
    "title": "Drugmaker Endo Begins Debt-Restructuring Talks With Creditors Amid Opioid Litigation",
    "sub_head": "Companyâ€™s debt prices fell this month as earnings were hit by loss of drug patent exclusivity",
    "time": "2022-05-18 16:42:00",
    "body": "Endo International PLC has started negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion in debt, according to people familiar with the matter, as the drugmaker faces litigation over opioid sales.<br />Lenders initiated the discussions after the pharmaceutical company reported a sharp drop in quarterly earnings earlier this month stemming from the loss of exclusive rights over a key drug, the people familiar with the matter also said.<br />Endo,..."
}